Evaluation of a procedure to assess the adverse effects of illicit drugs. by Amsterdam, J G C van et al.
 1 
Regulatory Toxicology and Pharmacology 
 
Evaluation of a procedure to assess the adverse effects of illicit drugs  
 
J.G.C. van Amsterdam, #W. Best, A. Opperhuizen and §F.A. de Wolff 
Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the 
Environment (RIVM), P.O. Box 1, 3720 BA Bilthoven, The Netherlands 
#Coordination point Assessment and Monitoring new drugs, Ministry of Health, Welfare and 
Sports, The Hague 
§Toxicology Laboratory, Leiden University Medical Center, Leiden, The Netherlands. 
 
Correspondence: Dr. J.G.C. van Amsterdam, RIVM-TOX, P.O. Box 1, 3720 BA Bilthoven, The 
Netherlands. E-mail:  JGC.van.Amsterdam@rivm.nl 
 
Abstract 
The assessment procedure of new synthetic illicit drugs that are not documented in the UN 
treaty on psychotropic drugs was evaluated an using the Electre model. Drugs were evaluated by 
an expert panel via the open Delphi approach, where the written score was discussed on 16 
items, covering medical, health, legal and criminalistic issues of the drugs. After this face-to-
face discussion the drugs were scored again. 
Taking the assessment of ketamine as an example, it appeared that each expert used its own 
scale to score, and that policy makers do not score deviant from experts trained in the medical-
biological field.  
Of the five drugs evaluated by the panel, p-methoxy-metamphetamine (PMMA), gamma-
hydroxybutyric acid (GHB) and 4-methylthio-amphetamine (MTA) were assessed as more 
adverse than ketamine and psilocine and psilocybine-containing mushrooms. Whereas some 
experts slightly adjusted during the assessment procedure their opinion on ketamine and 
PMMA, the opinion on mushrooms was not affected by the discussion held between the two 
scoring rounds. 
All experts rank the five drugs in a similar way on the adverse effect scale i.e. concordance scale 
of the Electre model, indicating unanimity in the expert panel with respect to the risk 
classification of these abused drugs. 
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Introduction 
In 1997 the European Council decided to start an Early Warning Mechanism (EWM) to assess 
the risk-benefit of new synthetic illicit drugs that are not documented in the UN-treaty on 
psychotropic drugs. For this reason the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) and Co-ordination point Assessment and Monitoring new drugs (CAM) 
were erected to support these actions at European and Dutch level, respectively.  
The Dutch assessment board (CAM) focuses on all new drugs: new chemical entities of natural 
and synthetic origin, new combinations and applications of known drugs including 
pharmaceuticals, mushrooms, herbs, and smart drugs like ecstacy. If applicable within the EWM 
the new drug will be reported to the European authorities of the EMCDDA. 
To assess such new drugs in the described way, the CAM has at her disposal a broadly oriented 
expert panel that evaluates the various properties of the drug ranging from biological activity to 
legal and criminalistic aspects. For an overview of the 16 items assessed by the expert panel cf. 
Table 1. 
The assessment procedure comprises of three steps; a written judgement for the 16 items (score 
1-5), a discussion about the various judgements using the Delphi approach (Dalkey and Helmer, 
1963), and finally a second written judgement.  
The aim of the present paper was to evaluate this assessment procedure which retains the 
character of a multiple criteria approach. The Electre model, as proposed by Roy (Roy, 1990; 
Roy, 1991), seems suitable to evaluate the assessment procedure used as it represents a multi-
criteria analysis based on the concept of outranking. 
 
Methods 
Assessment procedure 
The assessment procedure consists of three subsequent steps that finally results in a final 
judgement based on consensus. Consensus is attained by means of the oral Delphi method that, 
in contrast to the classical Delphi method (Dalkey and Helmer, 1963), is not anonymous but has 
the same iterative and expert character. The expert panel is represented by members with a 
different scientific backgrounds (ranging from medical biology and toxicology to criminology) 
and responsibilities (ranging from policy makers to drug prosecution officers). The number of 
experts may vary per assessment with the aim to attain a minimum quorum of 10 members. 
Several weeks before the assessment procedure is started, the experts receive an expert report 
(fact sheet), describing the relevant properties of the drug based on open literature and other 
sources available to the CAM. This information is presented in an objective way (controllable 
 3 
data) and used by the experts to give their initial written score on a form with 16 items. The 16 
items addressed are depicted in table 1, and fall in the following four categories: Individual 
health, Public health, Violation of civil order, and Criminal involvement. The score rages from 1 
to 5: 1 = no risk; 2 = low risk; 3 = risk is present; 4 = high risk; 5 = very high risk. The written 
score in the first round is discussed face-to-face by the expert panel, where the individual 
judgements are presented, clarified, exemplified and explained with the aim to get consensus. In 
the final round the experts give again their numerical scores from 1 to 5 on the 16 items to 
consider whether they have adjusted their initial judgement. The final judgement is made by the 
CAM and is based on the arguments made during the discussions rather than on average of the 
individual written scores. This procedure has now been evaluated using a modification of the 
Electre model originally developed by Roy (Roy, 1990; Roy, 1991).  
 
The Electre model 
The Electre model is chosen as basis to evaluate the multi-criteria assessment procedure as it 
enables to weight and quantify the scores given by the different experts. The model is based on 
the concept of outranking, originally due to Roy (Roy, 1990; Roy, 1991) and may be defined as 
follows. Option A outranks option B, if there are enough reasons to decide that option A is at 
least as good as B, while there is no overwhelming reason to refute the statement. Thus 
outranking is defined fundamentally at the level of pair-wise comparison between a certain drug 
and drug D being considered. 
All drugs are compared with an imaginary reference drug (drug D) for which the score on all 
criteria is set at 2.99. To each comparison of drug1 and drug D, a concordance coefficient c1,D is 
associated, capturing the idea of ‘at least as good’. There are different ways to define 
concordance. Here, in the modified Electre model, concordance is defined as the sum of the 
weights of those criteria for which the score of the drug x is higher than 2.99 (drug D). In 
addition, the notion of disconcordance (dx,D) captures the idea of ‘not considerably worse than 
drug D’, and is defined as the sum of weights of those criteria for which the score of the drug x 
is as high as or lower (i.e. ) than 2.99 (drug D). 
In this way the concordance (cx,D) and disconcordance (dx,D) indices can be calculated separately 
for each drug per expert or per group of experts (the expert panel). By plotting the cx,D-values on 
the ordinate against dx,D-values on the subordinate, the comparison of the different drugs 
examined is visualised. If necessary one can classify the different drugs, according to imposed 
limits for concordance and disconcordance, to drugs with higher and lesser adverse effects as 
compared with the reference drug. 
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Results 
The assessment of ketamine is chosen as an example of the assessment procedure. The 
phencyclidine derivative ketamine (Ketalar®, Ketaject®) is legally clinically used as a surgical 
anaesthetic, but is also illegally abused due to its hallucinogenic potential. Table 2 denotes the 
scores for ketamine on 16 items (depicted in Table 1) given by the expert panel in the first round 
and the second round following the open discussion. As can be referred from table 2, each 
expert uses its own scale to score so that the average value of the absolute height of scores is 
irrelevant. There proved to be no difference in scores between experts according to their 
scientific background i.e. experts trained in the medical-biological field (M-group) do not score 
deviant from policy makers (non M-group). Following the face-to-face discussion grossly the 
same total number of adjustments were made by the M-group and non M-group. However, nine 
adjustments were made by one single member of the M-group, whereas 12 adjustments were 
made by four out of the five non M-group members. Finally note that more adjustments were 
made on health aspects as compared to civil order and criminal aspects (15% and 5% of all 
scores, respectively). 
A visualisation of the change in opinion of some experts following the open discussion is 
presented in Figure 1. Note that a high concordance reflects a much higher risk as compared 
with drug B, whereas the reverse is true for a high disconcordance. The shift in assessment 
scores of expert number 1, 4, 5, and 8 in the upper-left direction reflects the lower scores given 
in the second round i.e. the drug is assessed in the second round as less adverse than before. 
Figure 2 represents the assessment scores (total score) of five different drugs given by the 
individual experts (three drugs are evaluated twice; two drugs only once). Clearly, the drugs p-
methoxy-metamphetamine (PMMA), gamma-hydroxybutyric acid (GHB) and 4-methylthio-
amphetamine (MTA) were assessed as being more adverse than ketamine and paddo’s 
(psilocine- and psilocybine-containing mushrooms). Whereas some experts slightly changed 
during the assessment procedure their opinion on ketamine and PMMA, the opinion on 
mushrooms was not affected by the discussion held between the two scoring rounds. In addition, 
it is again evident that each expert uses its own scale of scoring. Still, the parallelism in lines 
nicely illustrates that the experts rank the drugs in the same (or similar) way on the adverse 
effect scale i.e. concordance scale indicating unanimity in the expert panel considering the 
classification of these abused drugs. 
 
Discussion 
This paper shows that the assessment of five drugs by a panel consisting of experts from 
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different field of expertise and responsibilities leads to an unanimous decision to rank these 
drugs with respect to their adverse effects. In addition, the procedure to assess drugs using the 
Delphi approach is sound, and suitable to acquire such unanimous verdict. 
The adverse characteristics of illicit drugs are manifold and know a large variety of properties. 
In addition to adverse health effects like acute and long-term toxicity, psychological and 
physical dependence liability, illicit drugs may affect civil order and induce criminal assaults 
and violation. To obtain a sound and balanced verdict on the adverse character of drugs 16 items 
have been selected to cover these properties. The variety of drug properties evaluated demands 
that experts from different disciplines should be represented in the expert panel. Obviously, the 
complexity of the assessment i.e. different aspects considered by experts from different 
disciplines urges a well-balanced design of assessment. Last but not least, the assessment 
procedure may be frustrated by the subjectivity of the experts. 
To attain a sound assessment a procedure was selected based on two scoring rounds with an 
open Delphi approach in between. It should be noted here, that written information may 
introduce bias. This discussion has the aim to mutually exchange basic information. As 
expected, the experts evaluated the 16 items in the first round with a wide variation in score. It is 
important to note that following the face-to-face discussion, the scores showed a more consistent 
view i.e. the variation in scores (expressed as concordance and disconcordance value; cf. Fig. 1) 
was diminished. This clearly shows that the discussion is helpful and additive, and pursues some 
experts not only to reconsider their view but also to comply more with general view of the panel 
as a whole in order to build consensus. In addition, it is surprising to observe that most 
adjustments lead to a lower score than given in the first round indicating that the drugs is 
considered by the adjusting experts less adverse than previously thought. 
With respect to the ranking of five different illicit drugs, it is evident that experts use their 
personal scale to give the scores, but finally come to the same ranking order (cf. Fig 2). On the 
other hand, the discussion between the two scoring sessions does not dramatically affect the 
verdict of the majority of the experts. However, a closer view at the adjustment data of the 
ketamine assessment learns that more items were adjusted in the two health categories (15%) 
than in the other two categories (5%). Perhaps more importantly, four out of five experts without 
medical-biological background adjusted their opinion, whereas only one out of six medical-
biological experts changed his opinion. 
The reason of these deviations is not clear. Possibly, the basic information supplied to the 
experts in advance to the first round has essentially a medical-biological nature and is not well 
understood by the experts that are not familiar with medical-biological terminology (i.e. the non 
 6 
M-group). As such, these experts profit relatively more from the discussion where information is 
personally exchanged. 
In conclusion, the assessment procedure described gives a reliable judgement about, and enables 
comparison of the health hazards and psycho-criminal properties of a variety of drugs of abuse.  
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Table 1. Risk criteria used in the procedure to assess the adverse potential of drugs.  
Individual health 
  1. Physical dependence  
  2. Psychological dependence 
  3. Acute toxicity 
  4. Chronic toxicity 
 
 
 
 
Public health 
  5. Extent and frequency of use  
  6. Vulnerability of the user 
  7. Availability of information on possible 
effects of the drug 
  8. Availability of the drug 
  9. Reliability of the drug’s pharmaceutical 
quality  
10. Reliability of the drug’s distribution and sale 
11. Reported nature and extent of incidents 
Violation of civil order 
12. Annoyance to the general population 
13. Increased resort to use violence 
14. Impaired reaction time (traffic, 
labour) 
Criminal involvement 
15. Criminality with respect to the final product 
16. Criminality with respect to raw products 
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Table 2. Assessment of 16 items (risk criteria) of the drug ketamine by a panel of experts. The number in brackets denotes the score given in 
the second round if adjusted following the discussion. Only one score is given when the expert did not adjust his/her score. The symbol  
stands for the arbitrarily attributed weight factor per item. (M) denotes that this expert has medical-biological expertise. 
 Risk criterium assessed 
 Individual health  Public health  Violation of civil order  Criminal involvement 
 1 2 3 4  5 6 7 8 9 10 11  12 13 14  15 16 
 0.1 0.1 0.1 0.1   0.1 0.1 0.1 0.1 0.02 0.02 0.02  0.02 0.01 0.01  0.05 0.05 
Expert                    
  1 2 3 3 2  2 3 2 (2.5) 3 (2) 4 (2) 2 1  2 2 4  2 2 
  2 2 3 3.5 1.5  2 3 2.5 2.5 3 2.5 2  2 2.5 3  2.5 2 
  3 2 3 3 2  2 2 3 2 3 2 2  1 (3) 1 4  1 1 
  4 3 (1.5) 4 (2.5) 4 4 (2)  2 2 3.5 (3) 4 (3) 4.5 (2) 4.5 (3) 2  3 1 5  2 1.5 
  5 3 2 2 2  3 (2) 3 3 4 3 3 2  3 2 2  2 2 
  6 (M) 1 1 4 2  2 3 2 2 2 3 2  1 1 4  2 2.1 
  7 (M) 1 1 4 1  2 2 2 2 2 1 2  1 2 5  1 1 
  8 (M) 1.5 (1) 2.5 3 (4) 2.5 (2)  2 2 2 (3) 3.5 (2) 2 2 (3) 3 (2)  2 1 4 (5)  2 (1) 1 
  9 (M) 2 2 3 1.5  2 2 3 2 2 2 2  1 2 4  2 2.2 
10 (M) 1 3 2 3  2 2 3 2 2 3 1.5  1.5 1 5  1 1 
11 (M) 1 2 4 1.5  2 3 3 3 5 3 2  3 4 5  2 2 
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Figure 1. Concordance (cx,D) and disconcordance (dx,D) values representing the assessment 
score on ketamine calculated from the scores given by 11 experts (cf. Table 2). Open symbols 
refer to values based on scores given in the first round, whereas closed symbols (and asterisks) 
refer to values in the second round. Triangles refer to values that were not adjusted by the 
expert. Expert number 6 to 11 have medical-biological expertise. 
Figure 2. Concordance values representing the assessment score on five different drugs 
calculated from the scores given by 6 to 12 experts. The numbers given as additive to the 
drug’s name on the ordinate refer to round 1 and 2. PMMA: p-methoxy-methamphetamine; 
MTA: 4-methylthio-amphetamine; GHB: gamma-hydroxybutyric acid. 
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